Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Abiomed    ABMD

ABIOMED (ABMD)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 01/22 10:12:21 am
335.375 USD   +0.49%
2018ABIOMED : Good timing based on weekly price data
2018Two years in, Trump holds stock market bragging rights
RE
2014ABIOMED, INC. : quaterly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/15/2019 01/16/2019 01/17/2019 01/18/2019 01/22/2019 Date
325.61(c) 324.13(c) 330.32(c) 333.74(c) 332.68 Last
358 240 476 913 305 591 459 825 35 772 Volume
+3.29% -0.45% +1.91% +1.04% -0.32% Change
More quotes
Financials (USD)
Sales 2019 775 M
EBIT 2019 224 M
Net income 2019 232 M
Finance 2019 498 M
Yield 2019 -
Sales 2020 988 M
EBIT 2020 305 M
Net income 2020 220 M
Finance 2020 748 M
Yield 2020 -
P/E ratio 2019 66,24
P/E ratio 2020 68,28
EV / Sales2019 18,8x
EV / Sales2020 14,5x
Capitalization 15 031 M
More Financials
Company
Abiomed specializes in the development, manufacture and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - product sales (96.1%): heart pumps (Impella brand); - service provision (3.8%): including preventive... 
More about the company
Surperformance© ratings of Abiomed
Trading Rating : Investor Rating :
More Ratings
Latest news on ABIOMED
01/10ABIOMED : Third Quarter Fiscal 2019 Earnings and Conference Call Notification
BU
01/07ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
01/07ABIOMED : Announces Preliminary Q3 FY 2019 Revenue of $201 Million, Up 30% Over ..
BU
2018ABIOMED : to Present at the 37th Annual J.P. Morgan Healthcare Conference
AQ
2018ABIOMED : to Present at the 37th Annual J.P. Morgan Healthcare Conference
BU
2018ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior ..
AQ
2018MARKET SNAPSHOT: Stocks Close Sharply Lower As Dow Tumbles 600 Points In Wake..
DJ
2018ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior ..
BU
2018ABIOMED : Change in Directors or Principal Officers (form 8-K/A)
AQ
2018MARKET SNAPSHOT: Dow Finishes Nearly 550 Points Higher As Stocks Soar After M..
DJ
More news
Analyst Recommendations on ABIOMED
More recommendations
Stock Trading Strategies
ABIOMED - 2018
Good timing based on weekly price data
BUY
More Stock Trading Analysis
Sector news : Advanced Medical Equipment & Technology - NEC
01/21ROPER TECHNOLOGIES : U.K.'s CMA Refers Roper, Thermo Fisher Deal to Phase Two In..
DJ
01/18EUROPEAN PRESS ROUNDUP : The U.K.'s Uncertain Trade Deals, and Deutsche Bahn's F..
DJ
01/17ROYAL PHILIPS : Philips to close its UK factory in 2020, with loss of 400 jobs
RE
01/11SONY : Japan's Olympus to propose board seat for activist investor ValueAct
RE
01/10Hearing aid makers Widex and Sivantos reopen EU merger application
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ABIOMED
Duration : Period :
Abiomed Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABIOMED
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Average target price 438 $
Spread / Average Target 31%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED2.68%15 031
THERMO FISHER SCIENTIFIC7.54%96 884
DANAHER CORPORATION4.20%73 994
INTUITIVE SURGICAL13.29%61 959
BOSTON SCIENTIFIC CORPORATION6.65%52 155
ILLUMINA4.27%45 974